Delivery of alginate-chitosan hydrogel promotes endogenous repair and preserves cardiac function in rats with myocardial infarction

Journal of Biomedical Materials Research - Part A

Volumn 103, Issue 3, 2015, Pages 907-918

  Deng, Biyong ^a   Shen, Li ^a   Wu, Yizhe ^a   Shen, Yunli ^b   Ding, Xuefeng ^a   Lu, Shuyang ^a   Jia, Jianguo ^a   Qian, Juying ^a   Ge, Junbo ^a  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

Biomaterial; Cardiac; Infarction; Tissue engineering

Indexed keywords

ALGINATE; ANIMALS; BIOLOGICAL MATERIALS; BIOMATERIALS; CELL DEATH; CHITIN; CHITOSAN; HEART; HYDROGELS; REPAIR; STEM CELLS; TISSUE ENGINEERING;

BONE AND CARTILAGES; CARDIAC; CARDIAC STEM CELLS; CARDIAC TISSUE ENGINEERING; CHITOSAN COMPOSITES; INFARCTION; MYOCARDIAL INFARCTION; THERAPEUTIC EFFICACY;

TISSUE;

ALGINIC ACID; BIOMATERIAL; CHITOSAN; GLUCURONIC ACID; HEXURONIC ACID; HYDROGEL;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIODEGRADATION; BIOLOGICAL ACTIVITY; CELL CYCLE; CELL INFILTRATION; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; FIBROSIS; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HYDROGEL; HYDROGEN BOND; INFLAMMATION; MALE; NONHUMAN; RAT; SCAR; THICKNESS; TISSUE ENGINEERING; TISSUE LEVEL; TISSUE REGENERATION; TISSUE REPAIR; ANIMAL; CHEMISTRY; DISEASE MODEL; HEART MUSCLE; INFRARED SPECTROSCOPY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; REGENERATION; REGENERATIVE MEDICINE; SHEAR STRENGTH; SPRAGUE DAWLEY RAT; TEMPERATURE;

ALGINATES; ANIMALS; APOPTOSIS; BIOCOMPATIBLE MATERIALS; CELL PROLIFERATION; CHITOSAN; DISEASE MODELS, ANIMAL; FIBROSIS; GLUCURONIC ACID; HEXURONIC ACIDS; HYDROGEL; HYDROGELS; INFLAMMATION; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; REGENERATION; REGENERATIVE MEDICINE; SHEAR STRENGTH; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TEMPERATURE; TISSUE ENGINEERING; VENTRICULAR REMODELING;

EID: 84923067078     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.35232     Document Type: Article

References (37)

1. Lloyd-Jones D, Adams R, Carnethon M., De Simone G, Ferguson TB, Flegal K, Ford E., Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y. Heart disease and stroke statistics-2009 update: A report from the american heart association statistics committee and stroke statistics subcommittee. Circulation 2009; 119:480-486.
2. Mann DL. Mechanisms and models in heart failure: A combinatorial approach. Circulation 1999; 100:999-1008.
3. Rowley JA, Madlambayan G, Mooney DJ. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 1999; 20:45-53.
4. Leor J, Aboulafia-Etzion S, Dar A., Shapiro L, Barbash IM, Battler A, Granot Y., Cohen S. Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation 2000; 102:III56-61.
5. Dar A, Shachar M, Leor J., Cohen S. Optimization of cardiac cel seeding and distribution in 3d porous alginate scaffolds. Biotechnol Bioeng 2002; 80:305-312.
6. Al-Shamkhani A DR. Radioiodination of alginate via covalently-bound tyrosinamide allows monitoring of its fate in vivo. Bioactive Compatible Polym 1995; 10:4-13.
7. Cabrales P, Tsai AG, Intaglietta M. Alginate plasma expander maintains perfusion and plasma viscosity during extreme hemo-dilution. Am J Physiol Heart Circ Physiol 2005; 288:H1708-1716.
8. Ikara Holdings I. Ik-5001 for the prevention of remodeling of the ventricle and congestive heart failure after acute myocardia infarction. NCT01226563; 2010.
9. Glicklis R, Shapiro L, Agbaria R., Merchuk JC, Cohen S. Hepato-cyte behavior within three-dimensional porous alginate scaffolds. Biotechnol Bioeng 2000; 67:344-353.
10. Ben-Ze'ev A, Robinson GS, Bucher NL, Farmer SR. Cell-cell and cell-matrix interactions differentially regulate the expression of hepatic and cytoskeletal genes in primary cultures of rat hepato-cytes. Proc Natl Acad Sci USA 1988; 85:2161-2165.
11. Pawar SN, Edgar KJ. Alginate derivatization: A review of chemistry, properties and applications. Biomaterials 2012; 33:3279-3305.
12. Thu B, Bruheim P, Espevik T., Smidsrod O, Soon-Shiong P, Skjak-Braek G. Alginate polycation microcapsules. II. Some functional properties. Biomaterials 1996; 17:1069-1079.
13. Li Z, Ramay HR, Hauch K.D., Xiao D., Zhang M. Chitosan-alginate hybrid scaffolds for bone tissue engineering. Biomaterials 2005; 26:3919-3928.
14. Li Z, Zhang M. Chitosan-alginate as scaffolding material for cartilage tissue engineering. J Biomed Mater Res Part A 2005; 75:485-493.
15. Chenite A, Chaput C, Wang D., Combes C, Buschmann MD, Hoemann C.D., Leroux JC, Atkinson BL, Binette F, Selmani A. Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 2000; 21:2155-2161.
16. Landa N, Miller L, Feinberg M.S., Holbova R., Shachar M, Freeman I, Cohen S., Leor J. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation 2008; 117:1388-1396.
17. Sankalia MG, Mashru RC, Sankalia J.M., Sutariya VB. Reversed chitosan-alginate polyelectrolyte complex for stability improvement of alpha-amylase: Optimization and physicochemical characterization. Eur J Pharm Biopharm 2007; 65:215-232.
18. Yu JH, Du YM, Zheng H. Blend films of chitosan-gelation. J Wuhan Univ 1999; 45:440-444.
19. Yu J, Christman KL, Chin E, Sievers R.E., Saeed M., Lee RJ. Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy. J Thorac Cardiovasc Surg 2009; 137:180-187.
20. Lu WN, Lu SH, Wang H.B., Li DX, Duan CM, Liu ZQ, Hao T, He W.J., Xu B., Fu Q, Song YC, Xie XH, Wang CY. Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel. Tissue Eng A 2009; 15: 1437-1447.
21. Wang H, Zhang X, Li Y., Ma Y, Zhang Y, Liu Z., Zhou J, Lin Q, Wang Y, Duan C, Wang C. Improved myocardial performance in infarcted rat heart by co-injection of basic fibroblast growth factor with temperature-responsive chitosan hydrogel. J Heart Lung Transplant 2010; 29:881-887.
22. Liu Z, Wang H, Wang Y., Lin Q, Yao A, Cao F., Li D, Zhou J, Duan C, Du Z, Wang Y, Wang C. The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myo-cardial microenvironment. Biomaterials 2012; 33:3093-3106.
23. Bearzi C, Rota M, Hosoda T., Tillmanns J, Nascimbene A, De Angelis A, Yasuzawa-Amano S, Trofimova I, Siggins RW, Lecapitaine N, Cascapera S, Beltrami AP, D'Alessandro DA, Zias E, Quaini F, Urbanek K, Michler RE, Bolli R, Kajstura J, Leri A, Anversa P. Human cardiac stem cells. Proc Natl Acad Sci USA 2007; 104:14068-14073.
24. Beltrami AP, Barlucchi L, Torella D., Baker M, Limana F, Chimenti S., Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114:763-776.
25. Souders CA, Bowers SL, Baudino TA. Cardiac fibroblast: The renaissance cell. Circ Res 2009; 105:1164-1176.
26. Lesman A, Gepstein L, Levenberg S. Vascularization shaping the heart. Ann NY Acad Sci 2010; 1188:46-51.
27. Migrino RQ, Young JB, Ellis S.G., White HD, Lundergan CF, Miller DP, Granger C.B., Ross AM, Califf RM, Topol EJ. End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The global utilization of streptokinase and t-pa for occluded coronary arteries (gusto)-i angiographic investigators. Circulation 1997; 96:116-121.
28. Huang NF, Yu J, Sievers R., Li S, Lee RJ. Injectable biopolymers enhance angiogenesis after myocardial infarction. Tissue Eng 2005; 11:1860-1866.
29. Christman KL, Vardanian AJ, Fang Q, Sievers R.E., Fok HH, Lee RJ. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ische-mic myocardium. J Am Coll Cardiol 2004; 44:654-660.
30. Sy JC, Seshadri G, Yang S.C., Brown M., Oh T, Dikalov S, Murthy N., Davis ME. Sustained release of a p38 inhibitor from noninflammatory microspheres inhibits cardiac dysfunction. Nat Mater 2008; 7:863-868.
31. Pasumarthi KB, Field LJ. Cardiomyocyte cell cycle regulation. Circ Res 2002; 90:1044-1054.
32. Jopling C, Sleep E, Raya M., Marti M, Raya A, Izpisua Belmonte JC. Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation. Nature 2010; 464:606-609.
33. Christman KL, Lee RJ. Biomaterials for the treatment of myocar-dial infarction. J Am Coll Cardiol 2006; 48:907-913.
34. Johnson TD, Christman KL. Injectable hydrogel therapies and their delivery strategies for treating myocardial infarction. Expert Opin Drug Deliv 2013; 10:59-72.
35. Rane AA, Christman KL. Biomaterials for the treatment of myocar-dial infarction: A 5-year update. J Am Coll Cardiol 2011; 58:2615-2629.
36. Jackson BM, Gorman JH III, Salgo IS, Moainie SL, Plappert T, St John-Sutton M, Edmunds LH Jr, Gorman RC. Border zone geometry increases wall stress after myocardial infarction: Contrast echocardiographic assessment. Am J Physiol Heart Circ Physiol 2003; 284:H475-479.
37. Plotkin M, Vaibavi SR, Rufaihah A.J., Nithya V., Wang J, Shachaf Y, Kofidis T., Seliktar D. The effect of matrix stiffness of injectable hydrogels on the preservation of cardiac function after a heart attack. Biomaterials 2014; 35:1429-1438.